AtriCure (ATRC) reported a Q4 adjusted net loss late Wednesday of $0.08 per diluted share, narrowing from a loss of $0.21 a year earlier.
Analysts surveyed by FactSet expected a loss of $0.16.
Revenue for the quarter ended Dec. 31 was $124.3 million, up from $106.5 million a year earlier.
Analysts surveyed by FactSet expected $121.3 million.
For full-year 2025, the company said it expects adjusted loss per share of between $0.57 and $0.64, and revenue of roughly $517 million to $527 million. Analysts surveyed by FactSet expect a loss of $0.60 and revenue of $522.3 million.
Shares of the company were down 4.5% in recent after-hours activity.
Price: 40.44, Change: -1.92, Percent Change: -4.53
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。